Projected inhibition of platelet aggregation with ticagrelor twice dailyvs.clopidogrel once daily based on patient adherence data (the TWICE project)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Projected inhibition of platelet aggregation with ticagrelor twice dailyvs.clopidogrel once daily based on patient adherence data (the TWICE project)

Published:2014-04-22 Issue:5 Volume:77 Page:746-755
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Vrijens Bernard¹²,Claeys Marc J.³,Legrand Victor⁴,Vandendriessche Eef⁵,Van de Werf Frans⁶

Affiliation:

1. MWV Healthcare; Richmond Virginia USA

2. Department of Biostatistics and Medical Informatics; CHU Sart Tilman; Liège Belgium

3. Department of Cardiology; Antwerp University Hospital; Edegem Belgium

4. Department of Cardiovascular Medicine; CHU Sart Tilman; Liege Belgium

5. AstraZeneca; Brussels Belgium

6. Department of Cardiovascular Medicine; University Hospitals; Leuven Belgium

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12275/fullpdf

Reference37 articles.

1. Advances in antiplatelet therapy;Michelson;Hematology Am Soc Hematol Educ Program,2011

2. Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment;Boden;J Intern Med,2012

3. Antiplatelet therapy in acute coronary syndromes;Menozzi;Expert Opin Pharmacother,2012

4. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy;Patrono;Chest,2004

5. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis;Snoep;Am Heart J,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in Dual Antiplatelet Therapy Use for Neurointerventional Procedures for the Management of Intracranial Aneurysms;Biomedicines;2023-08-09

2. Efficacy and Safety of Tramadol Hydrochloride Twice-Daily Sustained-Release Bilayer Tablets with an Immediate-Release Component for Chronic Pain Associated with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study;Clinical Drug Investigation;2022-04-18

3. Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout;Clinical Pharmacology & Therapeutics;2019-05-31

4. Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers;Frontiers in Pharmacology;2018-06-20

5. Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder;International Journal of Bipolar Disorders;2018-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3